Paper28069641
Differential Impact of Chronic Hyperglycemia on Humoral Versus Cellular Primary Alloimmunity.
Bishop NH and 4 others. Diabetes, 2017. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Differential Impact of Chronic Hyperglycemia on Humoral Versus Cellular Primary Alloimmunity. Papers, record 28069641. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28069641
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Differential Impact of Chronic Hyperglycemia on Humoral Versus Cellular Primary Alloimmunity.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus | Major topic |
| Graft Rejection | Major topic |
| Hyperglycemia | Major topic |
| Immunity, Cellular | Major topic |
| Immunity, Humoral | Major topic |
| T-Lymphocytes | Major topic |
| Animals | |
| Insulin | |
| Islets of Langerhans Transplantation | |
| Male | |
| Mice | |
| Mice, Inbred BALB C | |
| Mice, Inbred C57BL | |
| Mutation | |
| Transplantation, Homologous |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 DK099187 | NIDDK NIH HHS | United States | R01DK099187 | PubMed and NIH | NIH RePORTER |
| T32 AI007405 | NIAID NIH HHS | United States | T32AI007405 | PubMed and NIH | NIH RePORTER |
| T32 GM008497 | NIGMS NIH HHS | United States | T32GM008497 | PubMed and NIH | NIH RePORTER |
| UC4 DK104223 | NIDDK NIH HHS | United States | UC4DK104223 | PubMed and NIH | NIH RePORTER |
References24
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23192154 | B-cell depletion improves islet allograft survival with anti-CD45RB. | Cell Transplant | 2014 | https://conductscience.org/library/papers/23192154 | PubMed |
| 2 | 11981430 | New mouse model to study islet transplantation in insulin-dependent diabetes mellitus. | Transplantation | 2002 | https://conductscience.org/library/papers/11981430 | PubMed |
| 3 | 24273001 | Leptin metabolically licenses T cells for activation to link nutrition and immunity. | J Immunol | 2014 | https://conductscience.org/library/papers/24273001 | PubMed |
| 4 | 130384 | Induced and spontaneous diabetes mellitus and suppression of cell-mediated immunologic responses. Granuloma formation, delayed dermal reactivity and allograft rejection. | J Clin Invest | 1976 | https://conductscience.org/library/papers/130384 | PubMed |
| 5 | 9133560 | A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice. | Diabetes | 1997 | https://conductscience.org/library/papers/9133560 | PubMed |
| 6 | 8425668 | Effect of STZ administration on islet isograft and allograft survival in NOD mice. | Diabetes | 1993 | https://conductscience.org/library/papers/8425668 | PubMed |
| 7 | 24056628 | Effects of preexisting autoimmunity on heart graft prolongation after donor-specific transfusion and anti-CD154. | Transplantation | 2014 | https://conductscience.org/library/papers/24056628 | PubMed |
| 8 | 23016759 | Leptin deficiency modulates allograft survival by favoring a Th2 and a regulatory immune profile. [corrected]. | Am J Transplant | 2013 | https://conductscience.org/library/papers/23016759 | PubMed |
| 9 | 9884331 | A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse. | J Clin Invest | 1999 | https://conductscience.org/library/papers/9884331 | PubMed |
| 10 | 14616779 | Effects of streptozotocin on autoimmune diabetes in NOD mice. | Clin Exp Immunol | 2003 | https://conductscience.org/library/papers/14616779 | PubMed |
| 11 | 340468 | Immune response in the mutant diabetic C57BL/Ks-dt+ mouse. Discrepancies between in vitro and in vivo immunological assays. | J Clin Invest | 1978 | https://conductscience.org/library/papers/340468 | PubMed |
| 12 | 21752956 | Immunosuppressive effects of streptozotocin-induced diabetes result in absolute lymphopenia and a relative increase of T regulatory cells. | Diabetes | 2011 | https://conductscience.org/library/papers/21752956 | PubMed |
| 13 | 25131095 | Resistance of spontaneously diabetic Ins2(akita) mice to allograft tolerance induced by anti-CD154 therapy. | Transplant Proc | 2014 | https://conductscience.org/library/papers/25131095 | PubMed |
| 14 | 6966615 | Depressed immunological defence mechanisms in mice with experimentally induced diabetes. | Infect Immun | 1980 | https://conductscience.org/library/papers/6966615 | PubMed |
| 15 | 153868 | Immune responses of diabetic animals. Direct immunosuppressant effects of streptozotocin in mice. | Diabetologia | 1979 | https://conductscience.org/library/papers/153868 | PubMed |
| 16 | 6432388 | Alterations in immunological function in streptozotocin-induced murine diabetes mellitus: correction by islet cell transplantation. | Clin Immunol Immunopathol | 1984 | https://conductscience.org/library/papers/6432388 | PubMed |
| 17 | 17212763 | Diabetes induces rapid suppression of adaptive immunity followed by homeostatic T-cell proliferation. | Scand J Immunol | 2007 | https://conductscience.org/library/papers/17212763 | PubMed |
| 18 | 347001 | Impairment of cell-mediated immunity in mutation diabetic mice (db/db). | J Immunol | 1978 | https://conductscience.org/library/papers/347001 | PubMed |
| 19 | 23751893 | Murine animal models for preclinical islet transplantation: No model fits all (research purposes). | Islets | 2013 | https://conductscience.org/library/papers/23751893 | PubMed |
| 20 | 711130 | Recovery of immune system in diabetic mice after treatment with insulin. | Horm Metab Res | 1978 | https://conductscience.org/library/papers/711130 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37401013 | Contribution of animal models to diabetes research: Its history, significance, and translation to humans. | J Diabetes Investig | 2023 | https://conductscience.org/library/papers/37401013 | PubMed |
| 29844327 | Interferon-gamma drives programmed death-ligand 1 expression on islet β cells to limit T cell function during autoimmune diabetes. | Sci Rep | 2018 | https://conductscience.org/library/papers/29844327 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28069641
GET https://conductscience.org/api/papers/v1/28069641/references?page=2